nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—endothelium—melanoma	0.0199	0.0927	CbGeAlD
Amiloride—PLAU—blood vessel—melanoma	0.0184	0.0855	CbGeAlD
Amiloride—SCNN1A—hair follicle—melanoma	0.0172	0.0798	CbGeAlD
Amiloride—PLAU—neck—melanoma	0.0131	0.0612	CbGeAlD
Amiloride—SLC9A1—eye—melanoma	0.0103	0.048	CbGeAlD
Amiloride—ASIC2—head—melanoma	0.00966	0.045	CbGeAlD
Amiloride—SLC9A1—skin of body—melanoma	0.00897	0.0418	CbGeAlD
Amiloride—SCNN1G—mammalian vulva—melanoma	0.0087	0.0405	CbGeAlD
Amiloride—AOC1—mammalian vulva—melanoma	0.00854	0.0398	CbGeAlD
Amiloride—PLAU—skin of body—melanoma	0.0085	0.0396	CbGeAlD
Amiloride—PLAU—mammalian vulva—melanoma	0.00776	0.0361	CbGeAlD
Amiloride—SCNN1B—mammalian vulva—melanoma	0.00735	0.0342	CbGeAlD
Amiloride—SCNN1A—mammalian vulva—melanoma	0.00679	0.0316	CbGeAlD
Amiloride—SCNN1D—head—melanoma	0.00623	0.029	CbGeAlD
Amiloride—ASIC1—head—melanoma	0.00611	0.0284	CbGeAlD
Amiloride—SLC9A1—head—melanoma	0.00585	0.0272	CbGeAlD
Amiloride—PLAU—head—melanoma	0.00555	0.0258	CbGeAlD
Amiloride—SCNN1B—head—melanoma	0.00526	0.0245	CbGeAlD
Amiloride—SCNN1A—head—melanoma	0.00486	0.0226	CbGeAlD
Amiloride—SLC22A4—neck—melanoma	0.00461	0.0215	CbGeAlD
Amiloride—SCNN1D—lymph node—melanoma	0.00436	0.0203	CbGeAlD
Amiloride—Encephalopathy—Carmustine—melanoma	0.00431	0.0205	CcSEcCtD
Amiloride—AOC1—lymph node—melanoma	0.00428	0.0199	CbGeAlD
Amiloride—ASIC1—lymph node—melanoma	0.00428	0.0199	CbGeAlD
Amiloride—SLC9A1—lymph node—melanoma	0.0041	0.0191	CbGeAlD
Amiloride—Digestion impaired—Temozolomide—melanoma	0.004	0.0191	CcSEcCtD
Amiloride—PLAU—lymph node—melanoma	0.00389	0.0181	CbGeAlD
Amiloride—Pain in extremity—Vemurafenib—melanoma	0.0038	0.0181	CcSEcCtD
Amiloride—SCNN1B—lymph node—melanoma	0.00368	0.0171	CbGeAlD
Amiloride—SCNN1A—lymph node—melanoma	0.0034	0.0158	CbGeAlD
Amiloride—Foetor hepaticus—Docetaxel—melanoma	0.00313	0.0149	CcSEcCtD
Amiloride—Neck pain—Carmustine—melanoma	0.0028	0.0133	CcSEcCtD
Amiloride—Aplastic anaemia—Dactinomycin—melanoma	0.00278	0.0132	CcSEcCtD
Amiloride—Liver disorder—Docetaxel—melanoma	0.00261	0.0124	CcSEcCtD
Amiloride—Heartburn—Docetaxel—melanoma	0.00258	0.0123	CcSEcCtD
Amiloride—Coma—Carmustine—melanoma	0.00253	0.012	CcSEcCtD
Amiloride—Aplastic anaemia—Temozolomide—melanoma	0.00251	0.012	CcSEcCtD
Amiloride—Gynaecomastia—Carmustine—melanoma	0.00248	0.0118	CcSEcCtD
Amiloride—Alopecia—Vemurafenib—melanoma	0.00232	0.0111	CcSEcCtD
Amiloride—Back pain—Vemurafenib—melanoma	0.00221	0.0105	CcSEcCtD
Amiloride—Nasal congestion—Temozolomide—melanoma	0.00213	0.0102	CcSEcCtD
Amiloride—Thirst—Temozolomide—melanoma	0.00204	0.00972	CcSEcCtD
Amiloride—Hyponatraemia—Carmustine—melanoma	0.00202	0.00961	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00201	0.00957	CcSEcCtD
Amiloride—Cough—Vemurafenib—melanoma	0.002	0.00951	CcSEcCtD
Amiloride—Arthralgia—Vemurafenib—melanoma	0.00195	0.00928	CcSEcCtD
Amiloride—SLC22A1—head—melanoma	0.00185	0.00863	CbGeAlD
Amiloride—Hepatocellular injury—Docetaxel—melanoma	0.00178	0.00847	CcSEcCtD
Amiloride—Muscular weakness—Carmustine—melanoma	0.00177	0.00844	CcSEcCtD
Amiloride—Neutropenia—Dactinomycin—melanoma	0.00173	0.00827	CcSEcCtD
Amiloride—Muscular weakness—Temozolomide—melanoma	0.00171	0.00816	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0017	0.0081	CcSEcCtD
Amiloride—Abdominal distension—Temozolomide—melanoma	0.00169	0.00805	CcSEcCtD
Amiloride—Neutropenia—Carmustine—melanoma	0.00162	0.00774	CcSEcCtD
Amiloride—Decreased appetite—Vemurafenib—melanoma	0.00162	0.00773	CcSEcCtD
Amiloride—Gastrointestinal disorder—Vemurafenib—melanoma	0.00161	0.00768	CcSEcCtD
Amiloride—Fatigue—Vemurafenib—melanoma	0.00161	0.00767	CcSEcCtD
Amiloride—Haemoglobin—Bleomycin—melanoma	0.0016	0.00762	CcSEcCtD
Amiloride—Constipation—Vemurafenib—melanoma	0.0016	0.00761	CcSEcCtD
Amiloride—Haemorrhage—Bleomycin—melanoma	0.00159	0.00759	CcSEcCtD
Amiloride—Dysuria—Temozolomide—melanoma	0.00157	0.00748	CcSEcCtD
Amiloride—Neutropenia—Temozolomide—melanoma	0.00157	0.00748	CcSEcCtD
Amiloride—Pollakiuria—Temozolomide—melanoma	0.00155	0.00739	CcSEcCtD
Amiloride—Erectile dysfunction—Temozolomide—melanoma	0.00154	0.00736	CcSEcCtD
Amiloride—Depression—Carmustine—melanoma	0.00154	0.00735	CcSEcCtD
Amiloride—Depression—Temozolomide—melanoma	0.00149	0.00711	CcSEcCtD
Amiloride—Alopecia—Bleomycin—melanoma	0.00141	0.0067	CcSEcCtD
Amiloride—Haemoglobin—Carmustine—melanoma	0.0014	0.00666	CcSEcCtD
Amiloride—Haemorrhage—Carmustine—melanoma	0.00139	0.00662	CcSEcCtD
Amiloride—SLC22A4—lymph node—melanoma	0.00136	0.00634	CbGeAlD
Amiloride—Visual disturbance—Docetaxel—melanoma	0.00136	0.00649	CcSEcCtD
Amiloride—Haemoglobin—Temozolomide—melanoma	0.00135	0.00643	CcSEcCtD
Amiloride—Haemorrhage—Temozolomide—melanoma	0.00134	0.0064	CcSEcCtD
Amiloride—Asthenia—Vemurafenib—melanoma	0.00134	0.00638	CcSEcCtD
Amiloride—Visual impairment—Carmustine—melanoma	0.00134	0.00638	CcSEcCtD
Amiloride—Pruritus—Vemurafenib—melanoma	0.00132	0.00629	CcSEcCtD
Amiloride—Alopecia—Dactinomycin—melanoma	0.00131	0.00625	CcSEcCtD
Amiloride—Hyponatraemia—Docetaxel—melanoma	0.0013	0.00618	CcSEcCtD
Amiloride—Visual impairment—Temozolomide—melanoma	0.00129	0.00617	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00129	0.00615	CcSEcCtD
Amiloride—Pain in extremity—Docetaxel—melanoma	0.00129	0.00615	CcSEcCtD
Amiloride—Diarrhoea—Vemurafenib—melanoma	0.00128	0.00609	CcSEcCtD
Amiloride—Tinnitus—Temozolomide—melanoma	0.00125	0.00597	CcSEcCtD
Amiloride—Dizziness—Vemurafenib—melanoma	0.00123	0.00588	CcSEcCtD
Amiloride—Alopecia—Carmustine—melanoma	0.00123	0.00585	CcSEcCtD
Amiloride—Cough—Bleomycin—melanoma	0.00121	0.00576	CcSEcCtD
Amiloride—Vomiting—Vemurafenib—melanoma	0.00119	0.00566	CcSEcCtD
Amiloride—Alopecia—Temozolomide—melanoma	0.00119	0.00565	CcSEcCtD
Amiloride—Chest pain—Bleomycin—melanoma	0.00118	0.00562	CcSEcCtD
Amiloride—Orthostatic hypotension—Docetaxel—melanoma	0.00118	0.00562	CcSEcCtD
Amiloride—Rash—Vemurafenib—melanoma	0.00118	0.00561	CcSEcCtD
Amiloride—Dermatitis—Vemurafenib—melanoma	0.00118	0.0056	CcSEcCtD
Amiloride—Back pain—Carmustine—melanoma	0.00117	0.00558	CcSEcCtD
Amiloride—Headache—Vemurafenib—melanoma	0.00117	0.00557	CcSEcCtD
Amiloride—Cramp muscle—Docetaxel—melanoma	0.00116	0.00554	CcSEcCtD
Amiloride—Confusional state—Bleomycin—melanoma	0.00114	0.00543	CcSEcCtD
Amiloride—Tremor—Carmustine—melanoma	0.00113	0.0054	CcSEcCtD
Amiloride—Back pain—Temozolomide—melanoma	0.00113	0.00539	CcSEcCtD
Amiloride—Nausea—Vemurafenib—melanoma	0.00111	0.00528	CcSEcCtD
Amiloride—Tremor—Temozolomide—melanoma	0.00109	0.00522	CcSEcCtD
Amiloride—Angina pectoris—Docetaxel—melanoma	0.00109	0.00518	CcSEcCtD
Amiloride—Anorexia—Bleomycin—melanoma	0.00108	0.00514	CcSEcCtD
Amiloride—Vertigo—Temozolomide—melanoma	0.00105	0.005	CcSEcCtD
Amiloride—Neutropenia—Docetaxel—melanoma	0.00104	0.00497	CcSEcCtD
Amiloride—Palpitations—Temozolomide—melanoma	0.00103	0.00492	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Bleomycin—melanoma	0.00103	0.00491	CcSEcCtD
Amiloride—Chest pain—Carmustine—melanoma	0.00103	0.00491	CcSEcCtD
Amiloride—Cough—Temozolomide—melanoma	0.00102	0.00486	CcSEcCtD
Amiloride—Paraesthesia—Bleomycin—melanoma	0.00102	0.00484	CcSEcCtD
Amiloride—Dyspnoea—Bleomycin—melanoma	0.00101	0.0048	CcSEcCtD
Amiloride—Anorexia—Dactinomycin—melanoma	0.00101	0.00479	CcSEcCtD
Amiloride—Confusional state—Carmustine—melanoma	0.000995	0.00474	CcSEcCtD
Amiloride—Arthralgia—Temozolomide—melanoma	0.000995	0.00474	CcSEcCtD
Amiloride—Decreased appetite—Bleomycin—melanoma	0.000983	0.00469	CcSEcCtD
Amiloride—Jaundice—Docetaxel—melanoma	0.000969	0.00462	CcSEcCtD
Amiloride—Pain—Bleomycin—melanoma	0.000967	0.00461	CcSEcCtD
Amiloride—Confusional state—Temozolomide—melanoma	0.000962	0.00458	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000961	0.00458	CcSEcCtD
Amiloride—Anorexia—Carmustine—melanoma	0.000941	0.00448	CcSEcCtD
Amiloride—Feeling abnormal—Bleomycin—melanoma	0.000932	0.00444	CcSEcCtD
Amiloride—Decreased appetite—Dactinomycin—melanoma	0.000917	0.00437	CcSEcCtD
Amiloride—Fatigue—Dactinomycin—melanoma	0.000909	0.00433	CcSEcCtD
Amiloride—Anorexia—Temozolomide—melanoma	0.000909	0.00433	CcSEcCtD
Amiloride—Pain—Dactinomycin—melanoma	0.000902	0.0043	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Carmustine—melanoma	0.000899	0.00429	CcSEcCtD
Amiloride—Haemoglobin—Docetaxel—melanoma	0.000897	0.00428	CcSEcCtD
Amiloride—Haemorrhage—Docetaxel—melanoma	0.000893	0.00426	CcSEcCtD
Amiloride—Insomnia—Carmustine—melanoma	0.000893	0.00425	CcSEcCtD
Amiloride—Paraesthesia—Carmustine—melanoma	0.000886	0.00422	CcSEcCtD
Amiloride—Dyspnoea—Carmustine—melanoma	0.00088	0.00419	CcSEcCtD
Amiloride—Somnolence—Carmustine—melanoma	0.000877	0.00418	CcSEcCtD
Amiloride—Feeling abnormal—Dactinomycin—melanoma	0.000869	0.00414	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Temozolomide—melanoma	0.000869	0.00414	CcSEcCtD
Amiloride—Insomnia—Temozolomide—melanoma	0.000863	0.00411	CcSEcCtD
Amiloride—Gastrointestinal pain—Dactinomycin—melanoma	0.000862	0.00411	CcSEcCtD
Amiloride—Visual impairment—Docetaxel—melanoma	0.00086	0.0041	CcSEcCtD
Amiloride—Decreased appetite—Carmustine—melanoma	0.000858	0.00409	CcSEcCtD
Amiloride—Paraesthesia—Temozolomide—melanoma	0.000856	0.00408	CcSEcCtD
Amiloride—Gastrointestinal disorder—Carmustine—melanoma	0.000852	0.00406	CcSEcCtD
Amiloride—Dyspnoea—Temozolomide—melanoma	0.00085	0.00405	CcSEcCtD
Amiloride—Somnolence—Temozolomide—melanoma	0.000848	0.00404	CcSEcCtD
Amiloride—Pain—Carmustine—melanoma	0.000844	0.00402	CcSEcCtD
Amiloride—Constipation—Carmustine—melanoma	0.000844	0.00402	CcSEcCtD
Amiloride—Dyspepsia—Temozolomide—melanoma	0.00084	0.004	CcSEcCtD
Amiloride—Abdominal pain—Dactinomycin—melanoma	0.000834	0.00397	CcSEcCtD
Amiloride—Decreased appetite—Temozolomide—melanoma	0.000829	0.00395	CcSEcCtD
Amiloride—Gastrointestinal disorder—Temozolomide—melanoma	0.000823	0.00392	CcSEcCtD
Amiloride—Fatigue—Temozolomide—melanoma	0.000822	0.00392	CcSEcCtD
Amiloride—Constipation—Temozolomide—melanoma	0.000816	0.00389	CcSEcCtD
Amiloride—Pain—Temozolomide—melanoma	0.000816	0.00389	CcSEcCtD
Amiloride—Feeling abnormal—Carmustine—melanoma	0.000813	0.00388	CcSEcCtD
Amiloride—Asthenia—Bleomycin—melanoma	0.000811	0.00387	CcSEcCtD
Amiloride—Gastrointestinal pain—Carmustine—melanoma	0.000807	0.00385	CcSEcCtD
Amiloride—Pruritus—Bleomycin—melanoma	0.0008	0.00381	CcSEcCtD
Amiloride—Alopecia—Docetaxel—melanoma	0.000789	0.00376	CcSEcCtD
Amiloride—Feeling abnormal—Temozolomide—melanoma	0.000786	0.00375	CcSEcCtD
Amiloride—Abdominal pain—Carmustine—melanoma	0.00078	0.00372	CcSEcCtD
Amiloride—Gastrointestinal pain—Temozolomide—melanoma	0.00078	0.00372	CcSEcCtD
Amiloride—Asthenia—Dactinomycin—melanoma	0.000757	0.00361	CcSEcCtD
Amiloride—Abdominal pain—Temozolomide—melanoma	0.000754	0.00359	CcSEcCtD
Amiloride—Back pain—Docetaxel—melanoma	0.000752	0.00358	CcSEcCtD
Amiloride—Muscle spasms—Docetaxel—melanoma	0.000747	0.00356	CcSEcCtD
Amiloride—Diarrhoea—Dactinomycin—melanoma	0.000722	0.00344	CcSEcCtD
Amiloride—Vomiting—Bleomycin—melanoma	0.000719	0.00343	CcSEcCtD
Amiloride—Rash—Bleomycin—melanoma	0.000713	0.0034	CcSEcCtD
Amiloride—Dermatitis—Bleomycin—melanoma	0.000712	0.0034	CcSEcCtD
Amiloride—Asthenia—Carmustine—melanoma	0.000708	0.00338	CcSEcCtD
Amiloride—Palpitations—Docetaxel—melanoma	0.000687	0.00327	CcSEcCtD
Amiloride—Asthenia—Temozolomide—melanoma	0.000684	0.00326	CcSEcCtD
Amiloride—Cough—Docetaxel—melanoma	0.000678	0.00323	CcSEcCtD
Amiloride—Diarrhoea—Carmustine—melanoma	0.000675	0.00322	CcSEcCtD
Amiloride—Pruritus—Temozolomide—melanoma	0.000675	0.00322	CcSEcCtD
Amiloride—Nausea—Bleomycin—melanoma	0.000672	0.0032	CcSEcCtD
Amiloride—Vomiting—Dactinomycin—melanoma	0.00067	0.0032	CcSEcCtD
Amiloride—Rash—Dactinomycin—melanoma	0.000665	0.00317	CcSEcCtD
Amiloride—Chest pain—Docetaxel—melanoma	0.000662	0.00315	CcSEcCtD
Amiloride—Arthralgia—Docetaxel—melanoma	0.000662	0.00315	CcSEcCtD
Amiloride—Dizziness—Carmustine—melanoma	0.000653	0.00311	CcSEcCtD
Amiloride—Diarrhoea—Temozolomide—melanoma	0.000653	0.00311	CcSEcCtD
Amiloride—Confusional state—Docetaxel—melanoma	0.00064	0.00305	CcSEcCtD
Amiloride—Dizziness—Temozolomide—melanoma	0.000631	0.00301	CcSEcCtD
Amiloride—Vomiting—Carmustine—melanoma	0.000628	0.00299	CcSEcCtD
Amiloride—Nausea—Dactinomycin—melanoma	0.000626	0.00299	CcSEcCtD
Amiloride—Shock—Docetaxel—melanoma	0.000624	0.00297	CcSEcCtD
Amiloride—Rash—Carmustine—melanoma	0.000622	0.00297	CcSEcCtD
Amiloride—Dermatitis—Carmustine—melanoma	0.000622	0.00296	CcSEcCtD
Amiloride—Headache—Carmustine—melanoma	0.000618	0.00295	CcSEcCtD
Amiloride—Vomiting—Temozolomide—melanoma	0.000606	0.00289	CcSEcCtD
Amiloride—Anorexia—Docetaxel—melanoma	0.000605	0.00288	CcSEcCtD
Amiloride—Rash—Temozolomide—melanoma	0.000601	0.00287	CcSEcCtD
Amiloride—Dermatitis—Temozolomide—melanoma	0.000601	0.00286	CcSEcCtD
Amiloride—Headache—Temozolomide—melanoma	0.000598	0.00285	CcSEcCtD
Amiloride—Nausea—Carmustine—melanoma	0.000586	0.00279	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Docetaxel—melanoma	0.000578	0.00275	CcSEcCtD
Amiloride—Insomnia—Docetaxel—melanoma	0.000574	0.00273	CcSEcCtD
Amiloride—Paraesthesia—Docetaxel—melanoma	0.00057	0.00271	CcSEcCtD
Amiloride—Nausea—Temozolomide—melanoma	0.000567	0.0027	CcSEcCtD
Amiloride—Dyspnoea—Docetaxel—melanoma	0.000565	0.0027	CcSEcCtD
Amiloride—Somnolence—Docetaxel—melanoma	0.000564	0.00269	CcSEcCtD
Amiloride—Dyspepsia—Docetaxel—melanoma	0.000558	0.00266	CcSEcCtD
Amiloride—Decreased appetite—Docetaxel—melanoma	0.000551	0.00263	CcSEcCtD
Amiloride—Gastrointestinal disorder—Docetaxel—melanoma	0.000548	0.00261	CcSEcCtD
Amiloride—Fatigue—Docetaxel—melanoma	0.000547	0.00261	CcSEcCtD
Amiloride—Pain—Docetaxel—melanoma	0.000542	0.00259	CcSEcCtD
Amiloride—Constipation—Docetaxel—melanoma	0.000542	0.00259	CcSEcCtD
Amiloride—Feeling abnormal—Docetaxel—melanoma	0.000523	0.00249	CcSEcCtD
Amiloride—Gastrointestinal pain—Docetaxel—melanoma	0.000519	0.00247	CcSEcCtD
Amiloride—Abdominal pain—Docetaxel—melanoma	0.000501	0.00239	CcSEcCtD
Amiloride—Asthenia—Docetaxel—melanoma	0.000455	0.00217	CcSEcCtD
Amiloride—Pruritus—Docetaxel—melanoma	0.000449	0.00214	CcSEcCtD
Amiloride—Diarrhoea—Docetaxel—melanoma	0.000434	0.00207	CcSEcCtD
Amiloride—Dizziness—Docetaxel—melanoma	0.000419	0.002	CcSEcCtD
Amiloride—Vomiting—Docetaxel—melanoma	0.000403	0.00192	CcSEcCtD
Amiloride—Rash—Docetaxel—melanoma	0.0004	0.00191	CcSEcCtD
Amiloride—Dermatitis—Docetaxel—melanoma	0.0004	0.0019	CcSEcCtD
Amiloride—Headache—Docetaxel—melanoma	0.000397	0.00189	CcSEcCtD
Amiloride—Nausea—Docetaxel—melanoma	0.000377	0.0018	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CA—melanoma	0.000316	0.000549	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—melanoma	0.000315	0.000547	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAPK1—melanoma	0.000314	0.000546	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—EGFR—melanoma	0.000314	0.000546	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IFNA2—melanoma	0.000313	0.000545	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000311	0.000541	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PHGDH—melanoma	0.000307	0.000533	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LUM—melanoma	0.000307	0.000533	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—melanoma	0.000305	0.000531	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—SLC6A11—melanoma	0.000304	0.000529	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—HRAS—melanoma	0.000301	0.000523	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HPSE—melanoma	0.000301	0.000523	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.0003	0.000521	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—KRAS—melanoma	0.000297	0.000515	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CUBN—melanoma	0.000295	0.000513	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—AKT1—melanoma	0.000295	0.000512	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—HRAS—melanoma	0.000292	0.000508	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ITGB1—melanoma	0.000291	0.000506	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—melanoma	0.000288	0.0005	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SDHD—melanoma	0.000285	0.000496	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—BSG—melanoma	0.000285	0.000496	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CSPG4—melanoma	0.000285	0.000496	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—SLC6A11—melanoma	0.000283	0.000493	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GPAM—melanoma	0.000276	0.00048	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CA—melanoma	0.000272	0.000474	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HDAC6—melanoma	0.000272	0.000473	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HGF—melanoma	0.000266	0.000463	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CSF2—melanoma	0.000263	0.000458	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000263	0.000458	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NPPA—melanoma	0.000258	0.000449	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—AKT1—melanoma	0.000258	0.000448	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ITGB3—melanoma	0.000253	0.000439	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PRKCA—melanoma	0.000253	0.000439	CbGpPWpGaD
Amiloride—SLC9A1—Disease—VCAN—melanoma	0.000252	0.000438	CbGpPWpGaD
Amiloride—SLC9A1—Disease—WNT5A—melanoma	0.00025	0.000434	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ALB—melanoma	0.00025	0.000434	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ALB—melanoma	0.00025	0.000434	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ALB—melanoma	0.00025	0.000434	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ALB—melanoma	0.00025	0.000434	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ALB—melanoma	0.00025	0.000434	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000247	0.000429	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000242	0.000421	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLA2G6—melanoma	0.000235	0.000408	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RAC1—melanoma	0.000234	0.000407	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ARL2—melanoma	0.00023	0.0004	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MMP1—melanoma	0.000227	0.000394	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000226	0.000393	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CDK2—melanoma	0.000222	0.000387	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—VCAN—melanoma	0.000211	0.000367	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—FN1—melanoma	0.000207	0.000359	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS2—melanoma	0.000204	0.000355	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GAB2—melanoma	0.000201	0.000349	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CG—melanoma	0.000198	0.000344	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FASN—melanoma	0.000196	0.000341	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—EGF—melanoma	0.000196	0.00034	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CXCR4—melanoma	0.000189	0.000328	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HDAC2—melanoma	0.000189	0.000328	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FOXO4—melanoma	0.000189	0.000328	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000187	0.000325	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD44—melanoma	0.000187	0.000324	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—GRIN2A—melanoma	0.000186	0.000323	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF1—melanoma	0.000181	0.000315	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00018	0.000313	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP17A1—melanoma	0.000178	0.000309	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000174	0.000303	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CD—melanoma	0.000174	0.000302	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GRIN2A—melanoma	0.000173	0.000301	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT3—melanoma	0.000172	0.000299	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ALB—melanoma	0.000172	0.000298	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GNA11—melanoma	0.000168	0.000292	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000168	0.000292	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ALB—melanoma	0.000165	0.000286	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—FASN—melanoma	0.000164	0.000286	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000164	0.000284	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC5A5—melanoma	0.000162	0.000281	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000158	0.000275	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CD44—melanoma	0.000156	0.000272	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GNAQ—melanoma	0.000156	0.000272	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000152	0.000265	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB4—melanoma	0.000152	0.000264	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CB—melanoma	0.000152	0.000264	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN2B—melanoma	0.000151	0.000262	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1B1—melanoma	0.00015	0.00026	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—melanoma	0.000148	0.000258	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000147	0.000256	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD86—melanoma	0.000146	0.000253	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF1—melanoma	0.000141	0.000246	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IL2—melanoma	0.000139	0.000242	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000137	0.000238	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PDGFRA—melanoma	0.000137	0.000238	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PRKCA—melanoma	0.000136	0.000236	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERCC2—melanoma	0.000134	0.000234	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAP2K2—melanoma	0.000133	0.00023	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—PRKCA—melanoma	0.000127	0.000221	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACER3—melanoma	0.000126	0.00022	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TERT—melanoma	0.000126	0.000219	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HLA-A—melanoma	0.000126	0.000219	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RAC1—melanoma	0.000126	0.000218	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCB1—melanoma	0.000123	0.000214	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB1—melanoma	0.000121	0.00021	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HIF1A—melanoma	0.000121	0.00021	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—PRKCA—melanoma	0.000119	0.000206	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—melanoma	0.000118	0.000206	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACER3—melanoma	0.000118	0.000205	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NRAS—melanoma	0.000117	0.000203	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UGT2B10—melanoma	0.000116	0.000201	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PRKCA—melanoma	0.000114	0.000197	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ERCC2—melanoma	0.000113	0.000196	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK3—melanoma	0.000112	0.000195	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS2—melanoma	0.00011	0.000191	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOTCH1—melanoma	0.000109	0.000189	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UGT2B10—melanoma	0.000108	0.000187	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HS3ST5—melanoma	0.000107	0.000187	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK1—melanoma	0.000107	0.000185	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD80—melanoma	0.000106	0.000185	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APC—melanoma	0.000106	0.000185	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KIT—melanoma	0.000106	0.000185	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGF—melanoma	0.000105	0.000182	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KRAS—melanoma	0.000101	0.000175	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HS3ST5—melanoma	0.0001	0.000174	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BRAF—melanoma	9.98e-05	0.000173	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—PRKCA—melanoma	9.76e-05	0.00017	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAP2K1—melanoma	9.4e-05	0.000163	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BRAF—melanoma	9.38e-05	0.000163	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CD—melanoma	9.34e-05	0.000162	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—melanoma	9.24e-05	0.000161	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—PRKCA—melanoma	9.1e-05	0.000158	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—melanoma	8.94e-05	0.000155	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF2—melanoma	8.94e-05	0.000155	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—melanoma	8.89e-05	0.000155	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BRAF—melanoma	8.74e-05	0.000152	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—melanoma	8.58e-05	0.000149	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HRAS—melanoma	8.55e-05	0.000149	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MDM2—melanoma	8.36e-05	0.000145	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—melanoma	8.25e-05	0.000143	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLCB4—melanoma	8.15e-05	0.000142	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CB—melanoma	8.14e-05	0.000141	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD4—melanoma	8.12e-05	0.000141	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—melanoma	8.06e-05	0.00014	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MDM2—melanoma	7.86e-05	0.000137	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CD—melanoma	7.82e-05	0.000136	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—melanoma	7.72e-05	0.000134	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIP4K2A—melanoma	7.66e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC6A11—melanoma	7.66e-05	0.000133	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—melanoma	7.64e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLCB4—melanoma	7.59e-05	0.000132	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—melanoma	7.55e-05	0.000131	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—melanoma	7.54e-05	0.000131	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A5—melanoma	7.48e-05	0.00013	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTAP—melanoma	7.45e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MDM2—melanoma	7.32e-05	0.000127	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CTNNB1—melanoma	7.21e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BRAF—melanoma	7.18e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC6A11—melanoma	7.14e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIP4K2A—melanoma	7.14e-05	0.000124	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1A—melanoma	7.05e-05	0.000122	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTEN—melanoma	7.03e-05	0.000122	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—melanoma	7.02e-05	0.000122	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A5—melanoma	6.97e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTAP—melanoma	6.94e-05	0.000121	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CB—melanoma	6.81e-05	0.000118	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—melanoma	6.75e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BRAF—melanoma	6.7e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PHGDH—melanoma	6.64e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LUM—melanoma	6.64e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—melanoma	6.54e-05	0.000114	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HPSE—melanoma	6.51e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CUBN—melanoma	6.39e-05	0.000111	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—melanoma	6.29e-05	0.000109	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NRAS—melanoma	6.27e-05	0.000109	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LUM—melanoma	6.19e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PHGDH—melanoma	6.19e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SDHD—melanoma	6.17e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CSPG4—melanoma	6.17e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BSG—melanoma	6.17e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HPSE—melanoma	6.07e-05	0.000105	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MDM2—melanoma	6.02e-05	0.000105	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK3—melanoma	6.01e-05	0.000104	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPAM—melanoma	5.98e-05	0.000104	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CUBN—melanoma	5.96e-05	0.000104	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTEN—melanoma	5.89e-05	0.000102	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—melanoma	5.84e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SDHD—melanoma	5.75e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BSG—melanoma	5.75e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CSPG4—melanoma	5.75e-05	0.0001	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK1—melanoma	5.72e-05	9.94e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—melanoma	5.72e-05	9.93e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—melanoma	5.7e-05	9.91e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MDM2—melanoma	5.61e-05	9.75e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPAM—melanoma	5.57e-05	9.69e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—melanoma	5.4e-05	9.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MAPK1—melanoma	5.37e-05	9.33e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—melanoma	5.31e-05	9.24e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLA2G6—melanoma	5.08e-05	8.84e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MAPK1—melanoma	5.01e-05	8.7e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—melanoma	4.96e-05	8.62e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLA2G6—melanoma	4.74e-05	8.24e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HRAS—melanoma	4.59e-05	7.98e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—VCAN—melanoma	4.57e-05	7.94e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—melanoma	4.39e-05	7.63e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HRAS—melanoma	4.31e-05	7.49e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—VCAN—melanoma	4.26e-05	7.4e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—melanoma	4.15e-05	7.22e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MAPK1—melanoma	4.11e-05	7.15e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—melanoma	4.05e-05	7.04e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HRAS—melanoma	4.02e-05	6.98e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP17A1—melanoma	3.85e-05	6.7e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MAPK1—melanoma	3.84e-05	6.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GNA11—melanoma	3.64e-05	6.32e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP17A1—melanoma	3.59e-05	6.24e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—melanoma	3.57e-05	6.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FASN—melanoma	3.56e-05	6.19e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A5—melanoma	3.5e-05	6.09e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—melanoma	3.39e-05	5.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GNA11—melanoma	3.39e-05	5.89e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GNAQ—melanoma	3.38e-05	5.88e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CD44—melanoma	3.38e-05	5.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—melanoma	3.32e-05	5.78e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FASN—melanoma	3.32e-05	5.77e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HRAS—melanoma	3.3e-05	5.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A5—melanoma	3.26e-05	5.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1B1—melanoma	3.24e-05	5.64e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CD44—melanoma	3.15e-05	5.48e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GNAQ—melanoma	3.15e-05	5.48e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HRAS—melanoma	3.08e-05	5.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1B1—melanoma	3.02e-05	5.25e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—melanoma	2.67e-05	4.64e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—melanoma	2.49e-05	4.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PRKCA—melanoma	2.46e-05	4.27e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ERCC2—melanoma	2.44e-05	4.24e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PRKCA—melanoma	2.29e-05	3.98e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ERCC2—melanoma	2.27e-05	3.95e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—melanoma	1.92e-05	3.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—melanoma	1.86e-05	3.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—melanoma	1.79e-05	3.12e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—melanoma	1.73e-05	3.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CD—melanoma	1.69e-05	2.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—melanoma	1.67e-05	2.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CD—melanoma	1.58e-05	2.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—melanoma	1.56e-05	2.71e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CB—melanoma	1.47e-05	2.56e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—melanoma	1.46e-05	2.54e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CB—melanoma	1.37e-05	2.39e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—melanoma	1.36e-05	2.37e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTEN—melanoma	1.27e-05	2.22e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTEN—melanoma	1.19e-05	2.06e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—melanoma	8.99e-06	1.56e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—melanoma	8.38e-06	1.46e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—melanoma	7.35e-06	1.28e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—melanoma	6.85e-06	1.19e-05	CbGpPWpGaD
